Adalimumab drug page Clinical trials

Trials with Adalimumab

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
1Recruiting
14Countries
506Planned patients

Showing 1–2 of 2

De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease
Recruiting Phase 4 148 patients NCT04646187

BACKGROUND/RATIONALE: Treatment outcomes of patients with inflammatory bowel disease (IBD) have improved enormously during the past decade due to the use of anti-tumour necrosis factor (anti-TNF) therapy. As a result, 67 to 91% of paediat…

Belgium, Netherlands, Spain Mar 2021 – Mar 2026 Interventional
Combined with: Infliximab
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
Finished Phase 3 358 patients NCT02171429

This Phase III, double-blind, placebo and active-comparator controlled, multicenter study will investigate the efficacy and safety of etrolizumab in induction of remission in participants with moderately to severely active ulcerative colit…

United States, Argentina, Australia, Brazil and 7 more Nov 2014 – May 2020 Interventional
Combined with: Etrolizumab

Where the recruiting trials are